SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $76,150,000 | -30.7% | 41,769,000 | -8.1% | 0.03% | -34.1% |
Q3 2014 | $109,884,000 | +20.1% | 45,430,000 | -2.6% | 0.04% | +22.2% |
Q2 2014 | $91,527,000 | +16.4% | 46,623,000 | +0.2% | 0.04% | +12.5% |
Q1 2014 | $78,660,000 | +15.6% | 46,527,000 | +1.9% | 0.03% | +18.5% |
Q4 2013 | $68,041,000 | +22.1% | 45,646,000 | +0.5% | 0.03% | +12.5% |
Q3 2013 | $55,705,000 | +2.9% | 45,404,000 | +0.1% | 0.02% | -4.0% |
Q2 2013 | $54,115,000 | – | 45,356,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $5,117,000 | 4.90% |
SILVERBACK ASSET MANAGEMENT LLC | 18,209,000 | $33,322,000 | 4.30% |
RAVEN ROCK CAPITAL MANAGEMENT, LLC | 1,000,000 | $1,990,000 | 2.80% |
Verition Fund Management LLC | 5,504,000 | $10,062,000 | 2.26% |
CAMDEN ASSET MANAGEMENT L P /CA | 26,798,000 | $48,856,000 | 1.81% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $15,679,000 | 1.60% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 3,000,000 | $5,490,000 | 1.46% |
BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $8,782,000 | 1.40% |
Wellesley Asset Management | 12,564 | $23,006,000 | 1.35% |
WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $56,979,000 | 1.11% |